Efficacy and Safety of Bendamustine and Ibrutinib in Previously Untreated Patients With Chronic Lymphocytic Leukemia: Indirect Comparison.

Andrasiak, Iga; Rybka, Justyna; Knopinska-Posluszny, Wanda; Wrobel, Tomasz

Andrasiak, Iga; Rybka, Justyna; Knopinska-Posluszny, Wanda; Wrobel, Tomasz.

Afiliación

Andrasiak I; WroMedica Research Center, Wroclaw, Poland. Electronic address: igaandrasiak@gmail.com.
Rybka J; Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University, Wroclaw, Poland.
Knopinska-Posluszny W; Clinical Department of Hematology, Independent Public Healthcare Facility of the Ministry of Internal Affairs With Warmia and Mazury Oncology Centre, Olsztyn, Poland.
Wrobel T; Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University, Wroclaw, Poland.

Clin Lymphoma Myeloma Leuk ; 17(5): 268-273, 2017 05.

Article en En | MEDLINE | ID: mdl-28395851

Asunto(s)

Antineoplásicos/uso terapéutico; Clorhidrato de Bendamustina/uso terapéutico; Leucemia Linfocítica Crónica de Células B/tratamiento farmacológico; Pirazoles/uso terapéutico; Pirimidinas/uso terapéutico; Adenina/análogos & derivados; Supervivencia sin Enfermedad; Humanos; Leucemia Linfocítica Crónica de Células B/mortalidad; Piperidinas; Resultado del Tratamiento

Palabras clave

Bendamustine; CLL; First line of treatment; Ibrutinib; Indirect comparison

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Leucemia Linfocítica Crónica de Células B / Clorhidrato de Bendamustina / Antineoplásicos Tipo de estudio: Systematic_reviews Límite: Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google